Engineering tyrosine electron transfer pathways decreases oxidative toxicity in hemoglobin: implications for blood substitute design

Hemoglobin (Hb)-based oxygen carriers (HBOC) have been engineered to replace or augment the oxygen-carrying capacity of erythrocytes. However, clinical results have generally been disappointing due to adverse side effects linked to intrinsic heme-mediated oxidative toxicity and nitric oxide (NO) sca...

Descripción completa

Detalles Bibliográficos
Autores principales: Silkstone, Gary G.A., Silkstone, Rebecca S., Wilson, Michael T., Simons, Michelle, Bülow, Leif, Kallberg, Kristian, Ratanasopa, Khuanpiroon, Ronda, Luca, Mozzarelli, Andrea, Reeder, Brandon J., Cooper, Chris E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095908/
https://www.ncbi.nlm.nih.gov/pubmed/27470146
http://dx.doi.org/10.1042/BCJ20160243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095908/
https://www.ncbi.nlm.nih.gov/pubmed/27470146
http://dx.doi.org/10.1042/BCJ20160243

Ejemplares similares